Xiaodong Lyu

660 total citations
24 papers, 428 citations indexed

About

Xiaodong Lyu is a scholar working on Hematology, Molecular Biology and Genetics. According to data from OpenAlex, Xiaodong Lyu has authored 24 papers receiving a total of 428 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Hematology, 8 papers in Molecular Biology and 6 papers in Genetics. Recurrent topics in Xiaodong Lyu's work include Acute Myeloid Leukemia Research (11 papers), Acute Lymphoblastic Leukemia research (5 papers) and Cancer Genomics and Diagnostics (4 papers). Xiaodong Lyu is often cited by papers focused on Acute Myeloid Leukemia Research (11 papers), Acute Lymphoblastic Leukemia research (5 papers) and Cancer Genomics and Diagnostics (4 papers). Xiaodong Lyu collaborates with scholars based in China, South Korea and United States. Xiaodong Lyu's co-authors include Yongping Song, Ming Yi, Kongming Wu, Weiheng Zhao, Hanxiao Xu, Ruihua Fan, Yaping Xin, Qingju Li, Zhen Guo and Xianwei Wang and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

Xiaodong Lyu

18 papers receiving 421 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Xiaodong Lyu China 9 180 163 118 85 61 24 428
Romain Vuillefroy de Silly Switzerland 13 236 1.3× 122 0.7× 47 0.4× 66 0.8× 17 0.3× 15 635
Kathleen Dass United States 6 136 0.8× 156 1.0× 28 0.2× 179 2.1× 50 0.8× 17 458
Boyan Wang China 8 51 0.3× 182 1.1× 26 0.2× 71 0.8× 40 0.7× 14 356
Rachel N. Steinmetz United States 9 398 2.2× 189 1.2× 88 0.7× 28 0.3× 31 0.5× 17 590
Asako Tajima United States 12 98 0.5× 158 1.0× 90 0.8× 25 0.3× 27 0.4× 18 450
Huirong Ding China 11 110 0.6× 173 1.1× 24 0.2× 77 0.9× 44 0.7× 23 376
Haihui Gu China 12 111 0.6× 270 1.7× 23 0.2× 65 0.8× 58 1.0× 26 483
Ganga Gopinathan United Kingdom 5 140 0.8× 169 1.0× 19 0.2× 69 0.8× 24 0.4× 9 393
Cristina Olgasi Italy 11 63 0.3× 357 2.2× 78 0.7× 205 2.4× 41 0.7× 21 575
Marta Hergueta‐Redondo Spain 13 124 0.7× 438 2.7× 36 0.3× 184 2.2× 18 0.3× 16 632

Countries citing papers authored by Xiaodong Lyu

Since Specialization
Citations

This map shows the geographic impact of Xiaodong Lyu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaodong Lyu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaodong Lyu more than expected).

Fields of papers citing papers by Xiaodong Lyu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Xiaodong Lyu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaodong Lyu. The network helps show where Xiaodong Lyu may publish in the future.

Co-authorship network of co-authors of Xiaodong Lyu

This figure shows the co-authorship network connecting the top 25 collaborators of Xiaodong Lyu. A scholar is included among the top collaborators of Xiaodong Lyu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaodong Lyu. Xiaodong Lyu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Li, Yuchun, Linlin Wang, Jingyu Wang, Yaping Xin, & Xiaodong Lyu. (2024). Relationship between adipocytes and hematological tumors in the bone marrow microenvironment: a literature review. Translational Cancer Research. 13(10). 5691–5701.
3.
Yang, Hong, Yan Zhang, Xiaodong Lyu, et al.. (2024). Discovery of CZL-046 with an (S)-3-Fluoropyrrolidin-2-one Scaffold as a p300 Bromodomain Inhibitor for the Treatment of Multiple Myeloma. Journal of Medicinal Chemistry. 67(20). 18606–18628. 4 indexed citations
4.
Lyu, Xiaodong, Ting Jiao, & Shuanying Yang. (2023). EP12.01-08 Benefits of Afatinib and Osimertinib in a Patient with Lung Adenocarcinoma Harboring EGFR19Del/T790M/G724S Mutation. Journal of Thoracic Oncology. 18(11). S643–S643.
5.
Lyu, Xiaodong, Dandan Zhu, Yan Chen, et al.. (2022). Whole-genome sequencing as an alternative to analyze copy number abnormalities in acute myeloid leukemia and myelodysplastic syndrome. Leukemia & lymphoma. 63(10). 2301–2310.
6.
Lyu, Xiaodong, Tao Li, Dandan Zhu, et al.. (2022). Whole-genome sequencing as an alternative to analyze copy number abnormalities in AML, MDS and MM.. Journal of Clinical Oncology. 40(16_suppl). e19023–e19023. 1 indexed citations
7.
Lyu, Xiaodong, et al.. (2020). [Clonal heterogeneity and its prognostic significance in acute lymphoblastic leukemia].. PubMed. 59(8). 629–633. 1 indexed citations
8.
Lyu, Xiaodong, et al.. (2020). [Application and clinical study of clonal heterogeneity analysis in acute myeloid leukemia].. PubMed. 41(6). 483–489. 1 indexed citations
9.
Xu, Hanxiao, Xiaodong Lyu, Ming Yi, et al.. (2018). Organoid technology and applications in cancer research. Journal of Hematology & Oncology. 11(1). 116–116. 249 indexed citations
10.
Zhang, Xuhua, Linping Xu, Ruihua Fan, et al.. (2018). Genetic editing and interrogation with Cpf1 and caged truncated pre-tRNA-like crRNA in mammalian cells. Cell Discovery. 4(1). 36–36. 15 indexed citations
11.
Lyu, Xiaodong, et al.. (2018). Identification of a novel nonsense mutation in SH2D1A in a patient with X-linked lymphoproliferative syndrome type 1: a case report. BMC Medical Genetics. 19(1). 60–60. 3 indexed citations
12.
Lyu, Xiaodong, Xianwei Wang, Lina Zhang, et al.. (2017). Detection of 22 common leukemic fusion genes using a single-step multiplex qRT-PCR-based assay. Diagnostic Pathology. 12(1). 55–55. 10 indexed citations
13.
Guo, Zhen, Shaokai Zhang, Zhe Zou, Ruihua Fan, & Xiaodong Lyu. (2017). Prognostic significance of TET2 mutations in myelodysplastic syndromes: A meta-analysis. Leukemia Research. 58. 102–107. 16 indexed citations
14.
15.
Xin, Yaping, et al.. (2017). C1qTNF-related protein 1 improve insulin resistance by reducing phosphorylation of serine 1101 in insulin receptor substrate 1. Endocrine Journal. 64(8). 787–796. 18 indexed citations
16.
Lyu, Xiaodong, Xianwei Wang, Bing Liu, et al.. (2016). A novel BCR-ABL1 fusion gene identified by next-generation sequencing in chronic myeloid leukemia. Molecular Cytogenetics. 9(1). 47–47. 8 indexed citations
17.
Lyu, Xiaodong, Yaping Xin, Jing Ding, et al.. (2014). Overexpression of Wilms Tumor 1 Gene as a Negative Prognostic Indicator in Acute Myeloid Leukemia. PLoS ONE. 9(3). e92470–e92470. 32 indexed citations
18.
Guo, Yongjun, Jie Ma, Xiaodong Lyu, et al.. (2014). Non-small cell lung cancer with EML4-ALKtranslocation in Chinese male never-smokers is characterized with early-onset. BMC Cancer. 14(1). 834–834. 14 indexed citations
19.
Xin, Yaping, et al.. (2014). Elevated circulating levels of CTRP1, a novel adipokine, in diabetic patients. Endocrine Journal. 61(9). 841–847. 46 indexed citations
20.
Li, Ling, Xiaodong Lyu, Lin Chen, et al.. (2013). [Detection of NPM1, FLT3 and C-KIT mutations in acute myeloid leukemia and their prognostic analysis].. PubMed. 21(3). 601–6. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Romain Vuillefroy de Silly Breakdown of academic impact, for papers by Kathleen Dass Breakdown of academic impact, for papers by Boyan Wang Breakdown of academic impact, for papers by Rachel N. Steinmetz Breakdown of academic impact, for papers by Asako Tajima Breakdown of academic impact, for papers by Huirong Ding Breakdown of academic impact, for papers by Haihui Gu Breakdown of academic impact, for papers by Ganga Gopinathan Breakdown of academic impact, for papers by Cristina Olgasi Breakdown of academic impact, for papers by Marta Hergueta‐Redondo
Rankless by CCL
2026